Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Baxter
Dow
Medtronic

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Disopyramide phosphate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for disopyramide phosphate and what is the scope of patent protection?

Disopyramide phosphate is the generic ingredient in three branded drugs marketed by Nesher Pharms, Gd Searle Llc, Aurolife Pharma Llc, Interpharm, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Sun Pharm Industries, Superpharm, Teva, and Watson Labs, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for disopyramide phosphate. Seven suppliers are listed for this compound.

Recent Clinical Trials for disopyramide phosphate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AberdeenN/A
University of OxfordN/A

See all disopyramide phosphate clinical trials

Pharmacology for disopyramide phosphate
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for disopyramide phosphate
Synonyms for disopyramide phosphate
(+-)-alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide phosphate (1:1)
(R)-4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide phosphate
2-(1-(Ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)pyridinium phosphate
2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, (+-)-, phosphate (1:1)
2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, phosphate
2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, phosphate (1:1)
2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, phosphate (9CI)
2-Pyridineacetamide, alpha-(2-(diisopropylamino)ethyl)-alpha-phenyl-, phosphate
22059-60-5
3737-09-5 (Parent)
4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butanamide
4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide; phosphoric acid
4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide,phosphoric acid
4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide; phosphoric acid
a-[2-(diisopropylamino)ethyl]-a-phenyl-2-pyridineacetamide phosphate
AC1L1KKM
AC1Q6RT0
AC1Q7DLA
ACM22059605
alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide phosphate (1:1)
alpha-(2-Diisopropylaminoethyl)-alpha-phenyl-2-pyridineacetamide phosphate
API0002424
C07740
C21H29N3O.H3O4P
C21H32N3O5P
CCG-40209
CHEBI:4658
CHEMBL1201020
CPD000058438
D 6035
D00637
Disopyramid phosphate
Disopyramide phosphate (JAN/USP)
Disopyramide phosphate [USAN:BAN:JAN]
Disopyramide phosphate [USAN:USP:BAN:JAN]
DISOPYRAMIDE PHOSPHATE SALT
Disopyramide phosphate, European Pharmacopoeia (EP) Reference Standard
Disopyramide phosphate, United States Pharmacopeia (USP) Reference Standard
EINECS 244-756-1
EU-0100411
FT-0630479
HMS1920I14
HMS2094K15
HMS2234B16
HMS3259J21
HMS3261C04
HMS3369L05
HMS3652M20
HMS501I11
LP00411
LS-130131
MFCD00069254
MLS000028431
MolPort-003-666-169
NC00683
NCGC00093836-01
NCGC00093836-02
NCGC00093836-03
NCGC00093836-04
NCGC00261096-01
Norpace
Norpace (TN)
Norpace Cr
NSC-756744
NSC756744
O712
Pharmakon1600-01500261
S4143
SAM002264607
SC 13957
SC 7031 phosphate
SC-13957
SCHEMBL41810
SMR000058438
SPECTRUM1500261
SR-01000003039
SR-01000003039-2
SR-01000003039-6
SW196836-3
SW196836-4
Tox21_500411

US Patents and Regulatory Information for disopyramide phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070139-001 Jun 14, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070352-001 Dec 17, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Mayne Pharma DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070173-002 May 31, 1985 AB RX No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070186-001 Nov 18, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Nesher Pharms DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 071200-001 Dec 15, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Mallinckrodt
McKesson
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.